<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Sinovac Biotech Ltd — News on 6ix</title>
<link>https://6ix.com/company/sinovac-biotech-ltd</link>
<description>Latest news and press releases for Sinovac Biotech Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/sinovac-biotech-ltd" rel="self" type="application/rss+xml" />
<item>
<title>SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024</guid>
<pubDate>Thu, 30 Apr 2026 04:00:00 GMT</pubDate>
<description>BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today</description>
</item>
<item>
<title>SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-announces-nasdaq-hearings-panel-grants-continued-listing-2026-01-22</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-announces-nasdaq-hearings-panel-grants-continued-listing-2026-01-22</guid>
<pubDate>Thu, 22 Jan 2026 05:00:00 GMT</pubDate>
<description>BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today</description>
</item>
<item>
<title>Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-receives-nasdaq-notification-regarding-late-filing-2025-half-year-report-2026</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-receives-nasdaq-notification-regarding-late-filing-2025-half-year-report-2026</guid>
<pubDate>Sun, 04 Jan 2026 05:00:00 GMT</pubDate>
<description>BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today</description>
</item>
<item>
<title>SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-provides-update-antigua-high-court-order-and-auditor-engagement-2026-01-04</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-provides-update-antigua-high-court-order-and-auditor-engagement-2026-01-04</guid>
<pubDate>Sun, 04 Jan 2026 05:00:00 GMT</pubDate>
<description>BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today</description>
</item>
<item>
<title>Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-antigua-court-makes-interim-order-giving-board-control-company-until-trial</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-antigua-court-makes-interim-order-giving-board-control-company-until-trial</guid>
<pubDate>Wed, 17 Dec 2025 05:00:00 GMT</pubDate>
<description>BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today</description>
</item>
<item>
<title>SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-announces-receipt-nasdaq-notice-delisting-and-intention-appeal-2025-11-18</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-announces-receipt-nasdaq-notice-delisting-and-intention-appeal-2025-11-18</guid>
<pubDate>Tue, 18 Nov 2025 05:00:00 GMT</pubDate>
<description>BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China,</description>
</item>
<item>
<title>SINOVAC Announces Appointment of Independent Auditor</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-announces-appointment-independent-auditor-2025-10-24</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-announces-appointment-independent-auditor-2025-10-24</guid>
<pubDate>Fri, 24 Oct 2025 04:00:00 GMT</pubDate>
<description>Critical step in improving transparency and resuming trading on NASDAQ BEIJING--(BUSINESS WIRE)-- The Board of Directors and Management of SINOVAC Biotech</description>
</item>
<item>
<title>SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-sets-record-straight-july-8-special-meeting-shareholders-2025-07-11</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-sets-record-straight-july-8-special-meeting-shareholders-2025-07-11</guid>
<pubDate>Fri, 11 Jul 2025 04:00:00 GMT</pubDate>
<description>Special Meeting validly adjourned until the appropriate court makes a final decision on validity of the PIPE shares and will be reconvened SAIF and the</description>
</item>
<item>
<title>Newly Elected Directors of Sinovac Hold the First Board Meeting</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/newly-elected-directors-sinovac-hold-first-board-meeting-2025-07-10</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/newly-elected-directors-sinovac-hold-first-board-meeting-2025-07-10</guid>
<pubDate>Thu, 10 Jul 2025 04:00:00 GMT</pubDate>
<description>Mr. Andrew Y. Yan elected Chairman of the Board New Board Unanimously Resolved to Explore Future Dividend Plans, Conduct Search for New Auditor for Resuming</description>
</item>
<item>
<title>SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-strongly-denounces-deceptive-and-illegal-claims-saif-and</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-strongly-denounces-deceptive-and-illegal-claims-saif-and</guid>
<pubDate>Wed, 09 Jul 2025 04:00:00 GMT</pubDate>
<description>Special Meeting was validly adjourned until the appropriate court can make a final decision on the validity of the PIPE shares SAIF’s “announcement” about</description>
</item>
<item>
<title>SINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend Payment</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-provides-update-status-us-5500-special-cash-dividend-payment</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-provides-update-status-us-5500-special-cash-dividend-payment</guid>
<pubDate>Wed, 09 Jul 2025 04:00:00 GMT</pubDate>
<description>Special cash dividend is being paid to valid common shareholders who owned SINOVAC as of the close of business on July 7, 2025 Board will continue to</description>
</item>
<item>
<title>SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE Shares</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-announces-adjournment-special-meeting-shareholders-until</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-announces-adjournment-special-meeting-shareholders-until</guid>
<pubDate>Wed, 09 Jul 2025 04:00:00 GMT</pubDate>
<description>On July 7 Antigua Court restricted PIPE shares from voting in Special Shareholder Meeting, but Eastern Caribbean Court of Appeal granted a temporary stay of</description>
</item>
<item>
<title>Final Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card "AGAINST" Misguided Proposals 1 and 2</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/final-reminder-sinovac-shareholders-vote-192600878</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/final-reminder-sinovac-shareholders-vote-192600878</guid>
<pubDate>Mon, 07 Jul 2025 19:26:00 GMT</pubDate>
<description>BEIJING, July 07, 2025--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today sent shareholders a final reminder to vote ahead of the Company’s Special Meeting of Shareholders (the "Special Meeting") on Tuesday, July 8, 2025 at 8:00 p.m. Atlantic Standard Time (Wednesday, July 9, 2025 at 8:00 a.m. China Standard Time).</description>
</item>
<item>
<title>Federal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVAC</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/federal-court-massachusetts-denies-vivo-054600246</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/federal-court-massachusetts-denies-vivo-054600246</guid>
<pubDate>Mon, 07 Jul 2025 05:46:00 GMT</pubDate>
<description>BEIJING, July 07, 2025--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that on June 30, the United States District Court for the District of Massachusetts denied Vivo Capital’s petition against 1Globe Capital LLC ("1Globe") for relief relating to SINOVAC’s shareholder votes and corporate governance. In its ruling, the Court concluded, "relief relating to governance outcomes or s</description>
</item>
<item>
<title>Final Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card “AGAINST” Misguided Proposals 1 and 2</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/final-reminder-sinovac-shareholders-vote-white-proxy-card-against-misguided-proposals</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/final-reminder-sinovac-shareholders-vote-white-proxy-card-against-misguided-proposals</guid>
<pubDate>Mon, 07 Jul 2025 04:00:00 GMT</pubDate>
<description>SINOVAC’s Board of Directors encourages shareholders to follow recommendations of leading independent proxy advisory firms ISS and Glass Lewis and VOTE to</description>
</item>
<item>
<title>Leading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in Place</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/leading-independent-proxy-advisory-firm-iss-joins-glass-lewis-recommending</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/leading-independent-proxy-advisory-firm-iss-joins-glass-lewis-recommending</guid>
<pubDate>Thu, 03 Jul 2025 04:00:00 GMT</pubDate>
<description>ISS states, “[T]he [current] board appears to be working to pay SVA shareholders their fair share of dividends, and to resume trading of the company's</description>
</item>
<item>
<title>United States District Court of Massachusetts Bars Activist 1Globe Capital and Jiaqiang Li From Making Further Materially Misleading Statements Regarding Sinovac</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/united-states-district-court-massachusetts-bars-activist-1globe-capital-and-jiaqiang</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/united-states-district-court-massachusetts-bars-activist-1globe-capital-and-jiaqiang</guid>
<pubDate>Wed, 02 Jul 2025 04:00:00 GMT</pubDate>
<description>Court Found That 1Globe and Li Likely Violated Disclosure Obligations; Mandates Both File Updated Disclosures Within 5 Days of Order Decision Cites Prolonged</description>
</item>
<item>
<title>Leading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in Place</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/leading-independent-proxy-advisory-firm-glass-lewis-recommends-sinovac-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/leading-independent-proxy-advisory-firm-glass-lewis-recommends-sinovac-shareholders</guid>
<pubDate>Wed, 02 Jul 2025 04:00:00 GMT</pubDate>
<description>Glass Lewis concludes, “[T]he current board has demonstrated credible progress in restoring governance stability and operational normalcy. [...] The</description>
</item>
<item>
<title>SINOVAC Board of Directors Urges Shareholders to Vote the WHITE Proxy Card “AGAINST” the Misguided Proposals to Remove SINOVAC’s Current Board</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-urges-shareholders-vote-white-proxy-card-against-misguided</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-urges-shareholders-vote-white-proxy-card-against-misguided</guid>
<pubDate>Mon, 30 Jun 2025 04:00:00 GMT</pubDate>
<description>Reaffirms Commitment to Declaring Dividends and New Dividend Policy Underscores Pledge to Work with NASDAQ Toward Resuming Trading Continues to Diligently</description>
</item>
<item>
<title>SINOVAC Board of Directors Prevails Against Advantech/Prime’s Lawsuit in Hong Kong</title>
<link>https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-prevails-against-advantech-primes-lawsuit-hong-kong-2025-06</link>
<guid isPermaLink="true">https://6ix.com/company/sinovac-biotech-ltd/news/sinovac-board-directors-prevails-against-advantech-primes-lawsuit-hong-kong-2025-06</guid>
<pubDate>Fri, 27 Jun 2025 04:00:00 GMT</pubDate>
<description>Hong Kong Court denies Advantech/Prime’s petition for Interim Relief Clears another legal hurdle for distribution of the US$55.00 per common share special</description>
</item>
</channel>
</rss>